Merck Mid-Afternoon Symposium: Clinical Management Of Upper Gastrointestinal (GI) Malignancies In Canada – Dr. Jonathan Cools-Lartigue

Promising Novel Agents In AML: The Role Of Menin Inhibitors

Navigating AML: Unraveling FLT3 Clonal Evolution For Better Patient Care

The Feasibility Of FLT3 Inhibitors In Combination Therapies: From Safety To Survival In AML

Best Of ASCO® Montreal 2024: Breast Cancer Updates – Dr. Jamil Asselah

Best Of ASCO® Montreal 2024: Lung Cancer – Dr. Jonathan Spicer

Best Of ASCO® Montreal 2024: Myeloma – Dr. Richard LeBlanc

Best Of ASCO® Montreal 2024: Gynecology Updates – Dr. Francois Panet

Best Of ASCO® Montreal 2024: Practice Changing Data From ASCO – Dr. Kim Ma

Best Of ASCO® Montreal 2024: EMD Serono Dinner Symposium: Exploring The Evolving Landscape Of Locally Advanced Squamous Cell Carcinoma Of Head & Neck – Practical Considerations – Dr. Houda Bahig & Dr. Denis Soulières

Best Of ASCO® Montreal 2024: Lower GI – Dr. Petr Kavan

Best Of ASCO® Montreal 2024: Upper GI – Dr. Nathalie Daaboul

Best Of ASCO® Montreal 2024: Head And Neck Cancer – Dr. Khashayar Esfahani

Best Of ASCO® Montreal 2024: Melanoma – Dr. Wilson Miller

Best Of ASCO® Montreal 2024: GU Cancer – Dr. Cristiano Ferrario

Best Of ASCO® Montreal 2024: Merck Mid-Afternoon Symposium: Clinical Management Of Upper Gastrointestinal (GI) Malignancies In Canada – Dr. Jonathan Cools-Lartigue

Best Of ASCO® Vancouver 2024: Prostate Cancer – Dr. Kim Chi

Best Of ASCO® Vancouver 2024: ASCO Palliative Care Updates – Dr. Pippa Hawley

Best Of ASCO® Vancouver 2024: CNS Updates – Dr. Manik Chahal

Best Of ASCO® Vancouver 2024: Breast Cancer – Dr. Nancy Nixon